Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
75.4 CHF | +0.76% | +7.06% | 0.00% |
May. 15 | Ten key beauty players | |
May. 10 | Europe sees two-speed IPO recovery as smaller deals lag | RE |
Sales 2024 * | 4.43B 4.02B | Sales 2025 * | 4.96B 4.5B | Capitalization | 19.67B 17.84B |
---|---|---|---|---|---|
Net income 2024 * | 218M 198M | Net income 2025 * | 468M 424M | EV / Sales 2024 * | 4.96 x |
Net Debt 2024 * | 2.31B 2.09B | Net Debt 2025 * | 1.81B 1.64B | EV / Sales 2025 * | 4.33 x |
P/E ratio 2024 * |
93.9
x | P/E ratio 2025 * |
39.9
x | Employees | - |
Yield 2024 * |
0.07% | Yield 2025 * |
0.33% | Free-Float | 0% |
Latest transcript on Galderma Group AG
1 day | +2.51% | ||
1 week | +5.26% | ||
Current month | +9.24% | ||
1 month | +19.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 75.1 | +0.36% | 6 481 |
24-05-16 | 74.83 | +2.51% | 304,091 |
24-05-15 | 73 | +2.33% | 205,630 |
24-05-14 | 71.34 | +1.91% | 285,431 |
24-05-13 | 70 | -0.21% | 134,250 |
Delayed Quote Swiss Exchange, May 16, 2024 at 11:30 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 19.67B | |
+0.63% | 264B | |
+19.72% | 20.89B | |
+15.62% | 12.52B | |
-11.59% | 9.53B | |
+21.66% | 8.03B | |
+10.61% | 6.01B | |
-1.54% | 4.49B | |
-12.98% | 4.01B | |
-3.37% | 3.65B |
- Stock Market
- Equities
- GALD Stock